IDAHO PHARMACY LAWS

1 UNOFFICIAL COPY IDAHO PHARMACY ~ IDAHO State Board of PHARMACY 1199 W Shoreline Lane Ste 303 PO Box 83720 Boise, ID 83720-0067 "~ Telephone (208) 334-2356 Fax (208) 334-3536 LAWS Title 54 Professions, Vocations & Businesses: Chapter 17 - Pharmacists Title 37 Food, Drugs & Oil: Chapter 27 - Uniform Controlled Substance Act Rules of the IDAHO State Board of PHARMACY Message from the Board Chairman Thank you for downloading the IDAHO PHARMACY Law book , which compiles select state laws relevant to the practice of PHARMACY in or into IDAHO . During the 2018 Legislative Session, the IDAHO Legislature enacted significant revisions to these laws, which were proposed by the IDAHO State Board of PHARMACY (BOP).

2 The BOP has acknowledged that changes in the education and training of pharmacists, as well as rapid advancements in the technology environment, have forced a change in approach to regulating the practice of PHARMACY . Rather than these laws being read as an itemized checklist of what pharmacists can do, the BOP has adopted an approach known as permissionless innovation that recognizes professionalism and allows for innovation in practice. Rule provides guidance to licensees as they determine whether a specific act is permissible. First, a licensee should consider whether the act is expressly prohibited by any state or federal law. If an act is not expressly prohibited, the licensee should consider whether: The act is consistent with the licensee or registrant s education, training or practice experience; and Performance of the act is within the accepted standard of care that would be provided in a similar setting by a reasonable and prudent licensee or registrant with similar education, training and experience.

3 Two questions that may help licensees successfully navigate this change in approach from prescriptive rules to professional judgment follow: 1. If someone asks why I made this decision, can I justify it as being consistent with good patient care and with law? 2. Would this decision withstand a test of reasonableness ( , would another prudent pharmacist make the same decision in this situation)? You should consult an attorney if you have questions as to the legality of your actions under the laws and rules regulating PHARMACY in the State of IDAHO . It is your responsibility to ensure that you are acting consistently with those laws and rules. The BOP hopes that you find this compilation of select state laws relevant to the practice of PHARMACY in or into IDAHO helpful.

4 Best regards, Nicole Chopski, PharmD Chairman Legislative Services Office Research & Legislation IDBOP Page | 1 TITLE 54 PROFESSIONS, VOCATIONS, AND BUSINESSES CHAPTER 17 PHARMACISTS TITLE. This chapter shall be known as the " IDAHO PHARMACY Act." DECLARATION. The practice of PHARMACY in the state of IDAHO is declared a professional practice affecting the health, safety and welfare of the public and is subject to regulation and control in the public interest. It is further declared to be a matter of public interest and concern that the practice of PHARMACY , as defined in this chapter, merits and receives the confidence of the public and that only qualified persons be permitted to engage in the practice of PHARMACY in or into the state of IDAHO .

5 This chapter shall be liberally construed to carry out these objects and purposes. OF PURPOSE. It is the purpose of this act to promote, preserve and protect the health, safety and welfare of the public by and through the effective control and regulation of the practice of PHARMACY and of the registration of drug outlets engaged in the manufacture, production, sale and distribution of drugs, medications, devices and such other materials as may be used in the diagnosis and treatment of injury, illness and disease. OF PHARMACY . "Practice of PHARMACY " means: (1) The interpretation, evaluation and dispensing of prescription drug orders; (2) Participation in drug and device selection, drug administration, prospective and retrospective drug reviews and drug or drug-related research; (3) The provision of patient counseling and the provision of those acts or services necessary to provide pharmaceutical care; (4) The responsibility for: (a) Compounding and labeling of drugs and devices, except labeling by a manufacturer, repackager or distributor of nonprescription drugs and commercially packaged legend drugs and devices.

6 (b) Proper and safe storage of drugs and devices, and maintenance of proper records for them; and (c) The offering or performing of those acts, services, operations or transactions necessary to the conduct, operation, management and control of PHARMACY ; (5) The prescribing of: (a) Dietary fluoride supplements when prescribed according to the American dental association's recommendations for persons whose drinking water is proven to have a fluoride content below the United States department of health and human services' recommended concentration; (b) Agents for active immunization when prescribed for susceptible persons six (6) years of IDBOP Page | 2 age or older for the protection from communicable disease; (c) Opioid antagonists pursuant to section 54- 1733B, IDAHO Code; (d) Epinephrine auto-injectors pursuant to sections 54- 1733C and 54- 1733D, IDAHO Code; (e) Drugs, drug categories or devices that are specifically authorized in rules adopted by the board.

7 Such drugs and devices shall be prescribed in accordance with the product's federal food and drug administration-approved labeling. Drugs, drug categories or devices authorized by the board under this section shall be limited to conditions that: (i) Do not require a new diagnosis; (ii) Are minor and generally self-limiting; (iii) Have a test that is used to guide diagnosis or clinical decision-making and are waived under the federal clinical laboratory improvement amendments of 1988; or (iv) In the professional judgment of the pharmacist, threaten the health or safety of the patient should the prescription not be immediately dispensed. In such cases, only sufficient quantity may be provided until the patient is able to be seen by another provider.

8 The board shall not adopt any rules authorizing a pharmacist to prescribe a controlled drug, compounded drug or biological product; (f) Tobacco cessation products pursuant to section 54- 1733E, IDAHO Code; and (g) Tuberculin purified protein derivative products pursuant to section 54-1733F, IDAHO Code. In this chapter: (1) "Board of PHARMACY " or "board" means the IDAHO state board of PHARMACY . (2) "Central drug outlet" means a resident or nonresident PHARMACY , drug outlet or business entity employing or contracting pharmacists to perform off-site PHARMACY services. (3) "Compounding" means the practice in which a pharmacist, a prescriber, or, in the case of an outsourcing facility, a person under the supervision of a pharmacist, combines, mixes or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.

9 (4) "Counseling" or "counsel" means the effective communication by the pharmacist of information, as set out in this chapter, to the patient or caregiver in order to improve therapeutic outcomes by maximizing proper use of prescription drugs and devices. Specific areas of counseling include, but are not limited to: (a) Name and strength and description of the drug; (b) Route of administration, dosage, dosage form, continuity of therapy and refill information; (c) Special directions and precautions for preparation, administration, storage and use by the patient as deemed necessary by the pharmacist; (d) Side effects or adverse effects and interactions and therapeutic contraindications that may be encountered, including their avoidance, which may interfere with the proper use of the drug or device as was intended by the prescriber, and the action required if they occur.

10 (e) Techniques for self-monitoring drug therapy; and (f) Action to be taken in the event of a missed dose. (5) "Deliver" or "delivery" means the actual, constructive or attempted transfer of a drug or device from one person to another, whether or not for a consideration. (6) "Device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar related article including any component part or accessory which is: IDBOP Page | 3 (a) Recognized in the official United States Pharmacopoeia or official National Formulary, other drug compendia or any supplement to them; (b) Intended for use in the diagnosis of disease or other conditions, or the cure, mitigation, treatment or prevention of disease in man or other animal.